> For the complete documentation index, see [llms.txt](https://www.brexatlas.org/llms.txt). Markdown versions of documentation pages are available by appending `.md` to page URLs; this page is available as [Markdown](https://www.brexatlas.org/author_index/research_gap_atlas.md). # RESEARCH\_GAP\_ATLAS The Research Gap Atlas represents the highest-priority unanswered questions identified from the analysis of the 44 foundational studies included in Volume I. A research gap does not mean the science is wrong. Instead, a research gap identifies areas where evidence is incomplete, contradictory, underdeveloped, or insufficient for confident translation. The purpose of the Research Gap Atlas is to guide future study selection, discovery validation, predictive modeling, ontology development, and clinical translation. ## RG-001 ### Frequency Specificity Validation Gap **Plain Language** Do different cancers truly respond best to different frequencies? **What Is Missing** Current evidence suggests frequency sensitivity exists, but comprehensive frequency maps do not yet exist for most cancer types. **Supporting Discoveries** * DISC-001 * DISC-028 **Supporting BRE Entries** * BRE-002 * BRE-021 * BRE-030 * BRE-043 **Why It Matters** Frequency optimization may become the foundation of future bioelectric oncology. ## RG-002 ### Universal Versus Tissue-Specific Frequency Gap **Plain Language** Are there frequencies that work broadly across cancers, or must every cancer be optimized individually? **What Is Missing** Cross-tissue frequency comparison remains limited. **Supporting Discoveries** * DISC-001 * DISC-019 * DISC-028 **Why It Matters** This question determines whether bioelectric oncology scales through standardization or personalization. ## RG-003 ### DNA Repair Mechanism Validation Gap **Plain Language** Exactly how do electric fields interfere with DNA repair? **What Is Missing** The biological pathway connecting TTFields to repair suppression remains incomplete. **Supporting Discoveries** * DISC-003 **Supporting BRE Entries** * BRE-003 * BRE-018 * BRE-019 * BRE-039 **Why It Matters** DNA repair vulnerability is one of the strongest discoveries in Volume I. ## RG-004 ### Combination Therapy Optimization Gap **Plain Language** What treatment combinations work best with bioelectric therapies? **What Is Missing** Optimal sequencing, timing, dosing, and treatment architecture remain unclear. **Supporting Discoveries** * DISC-004 * DISC-024 **Why It Matters** Combination amplification appears repeatedly throughout the evidence. ## RG-005 ### Calcium Antenna Validation Gap **Plain Language** Do calcium channels truly function as electromagnetic receivers? **What Is Missing** Independent validation across tissues and exposure systems. **Supporting Discoveries** * DISC-005 * DISC-012 * DISC-016 **Supporting BRE Entries** * BRE-030 * BRE-032 * BRE-043 **Why It Matters** This may represent one of the most important mechanisms in bioelectric oncology. ## RG-006 ### Membrane Potential Mapping Gap **Plain Language** Can cancer types be classified by bioelectric state? **What Is Missing** Large-scale membrane-potential atlases do not currently exist. **Supporting Discoveries** * DISC-006 * DISC-015 **Why It Matters** Bioelectric diagnostics may become possible. ## RG-007 ### Tumor Network Validation Gap **Plain Language** How important are tumor communication networks to survival and treatment resistance? **What Is Missing** Validation outside glioblastoma models. **Supporting Discoveries** * DISC-007 * DISC-017 * DISC-027 **Why It Matters** Tumor communication may become a therapeutic target. ## RG-008 ### Mitochondrial Vulnerability Validation Gap **Plain Language** Can cancer metabolism be reliably disrupted through bioelectric interventions? **What Is Missing** Replication across tissues and treatment systems. **Supporting Discoveries** * DISC-008 * DISC-020 * DISC-022 **Why It Matters** Cancer metabolism is a major future target. ## RG-009 ### Nanoparticle Delivery Gap **Plain Language** How can amplification nanoparticles be safely delivered to tumors? **What Is Missing** Clinical delivery systems. **Supporting Discoveries** * DISC-009 * DISC-014 * DISC-026 **Why It Matters** Precision Nanobioelectric Oncology depends on solving delivery. ## RG-010 ### Clinical Translation Scaling Gap **Plain Language** How can bioelectric therapies move from specialized applications into routine clinical use? **What Is Missing** Large-scale clinical validation. **Supporting Discoveries** * DISC-010 * DISC-021 * DISC-023 **Why It Matters** Clinical adoption depends on scalability. ## RG-011 ### Cross-Cancer Transferability Gap **Plain Language** Do mechanisms discovered in one cancer transfer into others? **Supporting Discoveries** * DISC-019 * DISC-025 **Why It Matters** The answer determines whether a universal bioelectric framework is possible. ## RG-012 ### Signal Architecture Gap **Plain Language** Which matters more: frequency, intensity, waveform, modulation, or exposure duration? **Supporting Discoveries** * DISC-018 * DISC-028 **Why It Matters** Future systems must optimize all parameters, not frequency alone. ## RG-013 ### Tumor-Specific Frequency Library Gap **Plain Language** Can a complete frequency library be built for cancer? **Supporting Discoveries** * DISC-001 * DISC-028 **Why It Matters** This is one of the long-term goals of BREXAtlas. ## RG-014 ### Bioelectric Biomarker Gap **Plain Language** Can bioelectric signatures predict treatment response? **Supporting Discoveries** * DISC-006 * DISC-015 **Why It Matters** Predictive modeling requires measurable biomarkers. ## RG-015 ### Bioelectric Bystander Signaling Gap **Plain Language** Can cells communicate stress responses through electrical mechanisms? **Supporting Discoveries** * DISC-029 **Supporting BRE Entries** * BRE-044 **Why It Matters** This could redefine how cellular communication is understood. ## Highest Priority Gaps The five gaps most likely to influence future discoveries are: 1. RG-001 Frequency Specificity Validation 2. RG-005 Calcium Antenna Validation 3. RG-007 Tumor Network Validation 4. RG-008 Mitochondrial Vulnerability Validation 5. RG-010 Clinical Translation Scaling These gaps directly influence the largest number of discoveries within the BREXAtlas framework. ## Research Gap Summary Volume I suggests that bioelectric oncology has advanced far enough to identify recurring patterns, but not far enough to fully explain them. The highest-priority future work involves: * frequency validation * calcium signaling * membrane potential mapping * tumor communication networks * mitochondrial vulnerability * nanoparticle amplification * clinical translation The purpose of Phase II is not to collect more papers. The purpose of Phase II is to systematically close these gaps, validate these discoveries, and expand the predictive power of the BREXAtlas knowledge framework. --- # Agent Instructions This documentation is published with GitBook. GitBook is the documentation platform designed so that both humans and AI agents can read, navigate, and reason over technical content effectively. Learn more at gitbook.com. ## Querying This Documentation If you need additional information that is not directly available in this page, you can query the documentation dynamically by asking a question. Perform an HTTP GET request on the current page URL with the `ask` query parameter, and the optional `goal` query parameter: ``` GET https://www.brexatlas.org/author_index/research_gap_atlas.md?ask=&goal= ``` `ask` is the immediate question: it should be specific, self-contained, and written in natural language. `goal` is optional and describes the broader end goal you are ultimately trying to accomplish on behalf of the user. GitBook uses it to tailor the answer towards what is most useful for that goal. The response will contain a direct answer to the question and relevant excerpts and sources from the documentation. Use this mechanism when the answer is not explicitly present in the current page, you need clarification or additional context, or you want to retrieve related documentation sections.